Merck Opposes Delay In Wind-Down Of Fosamax MDL

Merck Opposes Delay In Wind-Down Of Fosamax MDL

In a turnaround Friday, Merck & Co. Inc. urged a New York federal judge to stick to the planned wind-down of multidistrict litigation over jaw injuries allegedly caused by the bone drug Fosamax, after plaintiffs asked for a stay in the transfer of ...read more

  • Tags: